These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31223120)

  • 1. An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study.
    Tam T; Baer MR; Hsu LL; Law JY
    JMIR Mhealth Uhealth; 2019 Jun; 7(6):e13501. PubMed ID: 31223120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease.
    Rizio AA; Bhor M; Lin X; McCausland KL; White MK; Paulose J; Nandal S; Halloway RI; Bronté-Hall L
    Qual Life Res; 2020 Jun; 29(6):1533-1547. PubMed ID: 31933113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
    Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Attendance at a Sickle Cell Educational Conference Improve Clinician Knowledge and Attitude Toward Patients with Sickle Cell Disease?
    Jenerette CM; Brewer CA; Silva S; Tanabe P
    Pain Manag Nurs; 2016 Jun; 17(3):226-34. PubMed ID: 27283268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.
    Pittman DD; Hines PC; Beidler D; Rybin D; Frelinger AL; Michelson AD; Liu K; Gao X; White J; Zaidi AU; Charnigo RJ; Callaghan MU
    Blood; 2021 Apr; 137(15):2010-2020. PubMed ID: 33067606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive Crisis.
    Moody K; Abrahams B; Baker R; Santizo R; Manwani D; Carullo V; Eugenio D; Carroll A
    J Pain Symptom Manage; 2017 Jun; 53(6):1026-1034. PubMed ID: 28192225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Pilot Study: A Mobile Technology-based Self-management Intervention for Sickle Cell Pain.
    Ezenwa MO; Yao Y; Nguyen MT; Mandernach MW; Hunter CT; Yoon SL; Fedele D; Lucero RJ; Lyon D; Wilkie DJ
    West J Nurs Res; 2020 Aug; 42(8):629-639. PubMed ID: 31583977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Patient Activation Is Associated with Fewer Emergency Room Visits and Hospitalizations for Pain in Adults with Sickle Cell Disease.
    Cronin RM; Dorner TL; Utrankar A; Allen W; Rodeghier M; Kassim AA; Jackson GP; DeBaun MR
    Pain Med; 2019 Aug; 20(8):1464-1471. PubMed ID: 30329108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Abrams DI; Couey P; Dixit N; Sagi V; Hagar W; Vichinsky E; Kelly ME; Connett JE; Gupta K
    JAMA Netw Open; 2020 Jul; 3(7):e2010874. PubMed ID: 32678452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iCanCope with Sickle Cell Pain: Design of a randomized controlled trial of a smartphone and web-based pain self-management program for youth with sickle cell disease.
    Palermo TM; Zempsky WT; Dampier CD; Lalloo C; Hundert AS; Murphy LK; Bakshi N; Stinson JN
    Contemp Clin Trials; 2018 Nov; 74():88-96. PubMed ID: 30316999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers.
    Shah NR; Bhor M; Latremouille-Viau D; Kumar Sharma V; Puckrein GA; Gagnon-Sanschagrin P; Khare A; Kumar Singh M; Serra E; Davidson M; Xu L; Guerin A
    J Med Econ; 2020 Nov; 23(11):1345-1355. PubMed ID: 32815766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.
    Han J; Saraf SL; Gordeuk VR
    Pharmacotherapy; 2020 Jun; 40(6):535-543. PubMed ID: 32350885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study.
    Johnson A; Yang F; Gollarahalli S; Banerjee T; Abrams D; Jonassaint J; Jonassaint C; Shah N
    JMIR Mhealth Uhealth; 2019 Dec; 7(12):e13671. PubMed ID: 31789599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
    Osunkwo I; Andemariam B; Minniti CP; Inusa BPD; El Rassi F; Francis-Gibson B; Nero A; Trimnell C; Abboud MR; Arlet JB; Colombatti R; de Montalembert M; Jain S; Jastaniah W; Nur E; Pita M; DeBonnett L; Ramscar N; Bailey T; Rajkovic-Hooley O; James J
    Am J Hematol; 2021 Apr; 96(4):404-417. PubMed ID: 33264445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
    Zaidi AU; Glaros AK; Lee S; Wang T; Bhojwani R; Morris E; Donohue B; Paulose J; Iorga ŞR; Nellesen D
    Orphanet J Rare Dis; 2021 Nov; 16(1):460. PubMed ID: 34727959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.